Association Between the Pre-mir-218 Polymorphism and Cancer Risk in the Chinese Population: a Meta-Analysis |
Gao, Yue
(Molecular Medicine and Cancer Research Center, Chongqing Medical University)
Liu, Yan (Cardiac and Vascular Intensive Care Unit Washington Adventist Hospital) Liu, Ge-Li (Molecular Medicine and Cancer Research Center, Chongqing Medical University) Ran, Long-Ke (Molecular Medicine and Cancer Research Center, Chongqing Medical University) Zeng, Fan (Molecular Medicine and Cancer Research Center, Chongqing Medical University) Wu, Jia-Yan (Molecular Medicine and Cancer Research Center, Chongqing Medical University) Song, Fang-Zhou (Molecular Medicine and Cancer Research Center, Chongqing Medical University) |
1 | Uesugi A, Kozaki K, Tsuruta T, et al (2011). The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res, 71, 5765-78. DOI |
2 | Shi TY, Chen XJ, Zhu ML, et al (2013). A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. BMC Cancer, 13, 19. DOI |
3 | Tran N, O'Brien CJ, Clark J, et al (2010). Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck, 32, 1099-111. DOI ScienceOn |
4 | Tie J, Pan Y, Zhao L, et al (2010). MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet, 6, 1000879. DOI ScienceOn |
5 | Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103, 2257-61. DOI ScienceOn |
6 | Wu DW, Cheng YW, Wang J, et al (2010). Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res, 70, 10392-401. DOI ScienceOn |
7 | Wang B, Ma N, Wang YJ (2012). Association Between the hsamir- 27a variant and breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 6207-10 DOI ScienceOn |
8 | Zhou X, Chen X, Hu L, et al (2010). Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol, 117, 287-90. DOI ScienceOn |
9 | Zhang LS, Liang WB, Gao LB, et al (2012). Association Between pri-miR-218 Polymorphism and Risk of Hepatocellular Carcinoma in a Han Chinese Population. DNA Cell Biol, 31, 761-65. DOI ScienceOn |
10 | He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31. DOI ScienceOn |
11 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88 . DOI ScienceOn |
12 | Davidson MR , Larsen JE , Yang IA , et al (2010). MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One, 5, 12560. DOI ScienceOn |
13 | Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69 DOI ScienceOn |
14 | Han Y, Pu R, Han X, et al (2013). Association of a potential functional pre-miR-218 polymorphismand its interaction with hepatitis B virusmutations with hepatocellular carcinoma risk. Liver Int. [Epub ahead of print] |
15 | Higgins JP, Thompson SG (2002). Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. DOI ScienceOn |
16 | Kutanzi KR , Yurchenko OV, Beland FA, et al (2011). MicroRNAmediated drug resistance in breast cancer. Clin Epigenetics, 2, 171-85. DOI ScienceOn |
17 | Link A, Kupcinskas J, Wex T, et al (2012). Macro-role of microRNA in gastric cancer. Dig Dis, 30, 255-67. DOI ScienceOn |
18 | Martinez I, Gardiner AS, Board KF, et al (2008). Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene, 27, 2575-82. DOI ScienceOn |
19 | Liu Z, Wei S, Ma H, et al (2011). A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 32, 1668-74. DOI ScienceOn |
20 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
21 | Petrocca F, Visone R, Onelli MR, et al (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 13, 272-86. DOI ScienceOn |
22 | Anglicheau D, Muthukumar T, Suthanthiran M (2010). MicroRNAs: small RNAs with big effects. Transplantation, 90, 105-12. |
23 | Alajez NM, Lenarduzzi M, Ito E, et al (2011). MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res, 71, 2381-91. DOI |
24 | Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33. DOI ScienceOn |
25 | Chen K, Song F, Calin GA, et al (2008). Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis, 29, 1306-11. DOI ScienceOn |
26 | Chen AX, Yu KD, Fan L, et al (2011). Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet, 7, 1002259. DOI |
27 | Zhang YG, Shi JX, Song CH, et al (2013). Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pac J Cancer Prev, 14, 2337-42 DOI ScienceOn |
![]() |